CHANGES IN NEUTROPENIA OUTCOMES FOLLOWING IMPLEMENTATION OF THE CLOZAPINE RISK EVALUATION AND MITIGATION STRATEGY UPDATE

被引：0
|
作者：
Chang, J. [1 ]
Taylor, K. [1 ]
Wei, Y. [1 ]
Huang, T. Y. [1 ]
机构：
[1] Komodo Hlth, San Francisco, CA USA
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EPH16
引用
收藏
页码：S156 / S156
页数：1
相关论文
共 50 条
  • [21] Evaluation of a risk-guided strategy for empirical carbapenem use in febrile neutropenia
    Khoo, Ai Leng
    Zhao, Ying Jiao
    Teng, Monica
    Ying, Ding
    Jin, Jing
    Chee, Yen Lin
    Poon, Li Mei
    Lim, Siew Eng
    Koh, Liang Piu
    Chng, Wee Joo
    Lim, Boon Peng
    Hsu, Li Yang
    Chai, Louis Yi Ann
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2018, 52 (03) : 350 - 357
  • [22] Implementation and Integration of Risk Evaluation and Mitigation Strategies into the Health Care System
    Neyarapally, George A.
    Millikan, Edward D.
    Manzo, Claudia
    APPLIED CLINICAL INFORMATICS, 2023, 14 (02): : 354 - 355
  • [23] Potassium chloride for injection concentrate: Time for a risk evaluation and mitigation strategy
    Knox, Caitlin A.
    Liu, Wei
    Brushwood, David B.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2014, 71 (03) : 238 - 242
  • [24] Contraception Special Issue on the mifepristone Risk Evaluation and Mitigation Strategy (REMS)
    Cleland, Kelly
    Foster, Angel M.
    Gomez, Anu Manchikanti
    Raymond, Elizabeth G.
    Westhoff, Carolyn L.
    CONTRACEPTION, 2021, 104 (01) : 1 - 3
  • [25] Assessing the Opioid Analgesic Risk Evaluation and Mitigation Strategy Program Reply
    Heyward, James
    Sharfstein, Joshua
    Alexander, G. Caleb
    JAMA INTERNAL MEDICINE, 2020, 180 (06) : 916 - 916
  • [26] Association of a Risk Evaluation and Mitigation Strategy Program With Transmucosal Fentanyl Prescribing
    Fleischman, William
    Auth, Doris
    Shah, Nilay D.
    Agrawal, Shantanu
    Ross, Joseph S.
    JAMA NETWORK OPEN, 2019, 2 (03)
  • [27] Inpatient pharmacy experience with an audit for a risk evaluation and mitigation strategy for riociguat
    Smith, Zachary R.
    Makowski, Charles T.
    MacDonald, Nancy C.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2017, 74 (21) : 1762 - 1763
  • [28] SCOPE of Pain: An Evaluation of an Opioid Risk Evaluation and Mitigation Strategy Continuing Education Program
    Alford, Daniel P.
    Zisblatt, Lara
    Ng, Pamela
    Hayes, Sean M.
    Peloquin, Sophie
    Hardesty, Ilana
    White, Julie L.
    PAIN MEDICINE, 2016, 17 (01) : 52 - 63
  • [29] Navigating Neutropenia: Risk Factors and Outcomes Following Hyperthermic Intraperitoneal Chemotherapy with Mitomycin C
    Meehan, Cristina A.
    Perati, Shruthi R.
    Blakely, Andrew M.
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (01) : S237 - S237
  • [30] Risk evaluation and mitigation strategy compliance for pulmonary hypertension medications after policy implementation with computerized provider order entry support
    Liske, Joshua
    Patel, Nisha
    Makowski, Charles
    Awdish, Rana
    Smith, Zachary R.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2024, 82 (01) : 23 - 31
12345